scholarly journals Prevalence of NAFLD and Its Correlation with Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients

2021 ◽  
Vol 10 (11) ◽  
pp. 809-812
Author(s):  
Simran Kaur ◽  
Sushma Laxmareddygari ◽  
Nitin Gupta ◽  
Akshith Rajgupta Tabjula ◽  
Yavatesh Joshi ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Diabetic Nephropathy ◽  
Fatty Liver ◽  
Demographic Data ◽  
Significant Risk ◽  
Diabetic Patients ◽  
Alcoholic Fatty Liver

BACKGROUND Diabetes mellitus (DM) is a disease related to abnormality in metabolism of carbohydrates which is characterised by hyperglycemia that results from relative or absolute defect in insulin secretion, varying degrees of insulin resistance or both. Various researches have established the link between type 2 diabetes mellitus (T2DM) and non-alcoholic fatty liver disease (NAFLD). The present study was done for assessing the prevalence of NAFLD and its association with diabetic nephropathy in patients with type 2 diabetes mellitus. METHODS 75 patients of type 2 diabetes were included in this study. Clinical details and demographic data of all the patients were obtained. Samples were obtained from all the patients and all the routine investigations were carried out. Ultrasonography (USG) abdomen was performed in all patients after 12 hours fasting. Microsoft Excel was used for recording the results and were analysed by Statistical Package for the Social Sciences (SPSS) software. Level of significance was evaluated using chisquare test. RESULTS NAFLD was present in 57 patients. Therefore, the overall prevalence of NAFLD was see 76 %. The overall prevalence of diabetic nephropathy was 42 percent among diabetic patients. Out of 31 patients with diabetic nephropathy, NAFLD was present in 25 patients. Significant results were obtained while assessing the association of NAFLD with diabetic nephropathy in T2DM patients. CONCLUSIONS NAFLD was found to be a significant risk factor for the development of diabetic nephropathy in patients having type 2 diabetes mellitus. KEY WORDS Non-Alcoholic Fatty Liver, Diabetic Nephropathy, Type 2 Diabetes Mellitus, Nonalcoholic Steatohepatitis

scholarly journals Prevalence of non-alcoholic fatty liver disease in type-2 diabetes mellitus patients

2018 ◽  
Vol 6 (4) ◽  
pp. 1322 ◽  
Author(s):  
Hardik Patel ◽  
Yadav Narain Verma
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Liver Disease ◽  
Fatty Liver ◽  
Fatty Liver Disease ◽  
Diabetic Patients ◽  
Alcoholic Fatty Liver ◽  
Alcoholic Fatty Liver Disease

Background: Non-alcoholic fatty liver disease (NAFLD) is a common chronic condition of which diabetic fatty liver accounts for a large proportion, with 50 to 75% of the subjects demonstrating fat in the liver on ultrasound. As a result of epidemic increase in diabetes mellitus, hypertension, obesity and hyperlipidemia, the prevalence of NAFLD is increasing worldwide.Methods: A study was conducted on a total 100 type-2 diabetes mellitus patients attending Geetanjali Medical College and Hospital, Udaipur, Rajasthan. Patients with known chronic liver disease and history of alcohol intake were excluded. These patients were evaluated by abdominal ultrasonography to determine the presence of fatty liver. They were divided into fatty liver group and non-fatty liver group; and were further evaluated by measurement of body mass index, Central obesity, HbA1c and lipid profile. The data obtained was analyzed using SPSS version 20.0.Results: Of the 100 diabetic patients enrolled in this study, 64 (64%) presented with NAFLD. The highest prevalence of NAFLD was recorded in the age group of 50-59 years at 37.5%. The prevalence rate among males (65.62%) was higher than for females (34.38%). A comprised NAFLD patients (64%) and Non-NAFLD patients (34%).Conclusions: This study revealed that the NAFLD is a vital part of cluster of abnormalities such as dysglycemia, dyslipidemia, hypertension and obesity. Age and duration of diabetes are also important contributing factors in occurrence of NAFLD.

scholarly journals Assessment of Cystatin C and Microalbumin as Biomarkers for Nephropathy in Patients with Type 2 Diabetes Mellitus

2021 ◽  
Vol 10 (25) ◽  
pp. 1866-1870
Author(s):  
Bhuneshwar Yadav ◽  
Shashidhar K.N ◽  
Raveesha A ◽  
Muninarayana C.
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Diabetic Nephropathy ◽  
Cystatin C ◽  
Elevated Serum ◽  
Diabetic Patients ◽  
Serum Cystatin C ◽  
Serum Cystatin

BACKGROUND Increased levels of urinary biomarkers can be detected in type 2 diabetic patients before the onset of significant albuminuria and may be used as an early marker of renal injury in diabetic nephropathy (DN) which would play a significant role for the effective management and treatment approaches in diabetic care. We wanted to evaluate cystatin C and microalbumin as effective early biomarkers in assessing nephropathy in patients with type 2 diabetes mellitus in this study. METHODS A cross-sectional study was conducted among 180 subjects grouped into healthy controls, clinically proven T2DM without nephropathy and type 2 DM with nephropathy comprising 60 participants in each group. Fasting and postprandial blood samples and urine samples were collected and analysed by standard methods. eGFR was calculated using CKD-EPI 2012 equation. IBM - SPSS version 20 was used for statistical analysis. RESULTS Diabetic nephropathy patients had significantly elevated serum cystatin C and microalbumin (2.43 ± 0.59, 700.5 ± 591.8 mg / L, respectively), compared to T2DM (0.98 ± 0.26, 63.7 ± 102.9 mg / L, respectively), and the control study subjects (0.81 ± 0.16, 11.15 ± 8.9 mg / L, respectively). Serum cystatin C showed AUC of 0.994 (95 % CI, 0.986 - 1.00) whereas microalbumin showed 0.944 (95 % CI, 0.907 - 0.981). Serum cystatin C showed a sensitivity of 96.7 % and a specificity of 91.7 % at a cutoff point of 1.34 mg / L whereas at a cut-off point of 138.5 mg / L for microalbumin, the sensitivity and specificity were 90 % and 83.3 % respectively. CONCLUSIONS Serum cystatin C and microalbumin both could be considered as markers for early detection of nephropathy in T2DM patients. The more prominent rise in serum cystatin C values provide an earlier diagnosis of diabetic nephropathy among T2DM patients. KEY WORDS Biomarker, Type 2 Diabetes Mellitus, Cystatin C, Diabetic Nephropathy, Microalbumin

STUDY OF PREVALENCE AND CLINICAL PROFILE OF NEPHROPATHY AND RETINOPATHY IN TYPE 2 DIABETES PATIENTS AT TERTIARY CARE CENTER, UDAIPUR

2021 ◽  
pp. 6-8
Author(s):  
Yash Salil Patel
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Diabetic Retinopathy ◽  
Diabetic Nephropathy ◽  
Microvascular Complications ◽  
Tertiary Care ◽  
Positive Family History ◽  
Diabetic Patients

Microvascular complications of Type 2 Diabetes Mellitus (T2DM), (retinopathy and nephropathy) have a similar etiopathogenetic mechanism besides genetic predisposition. Even though these two complications frequently co-exist, their frequency varies. The association of these two signicant complications and their coexistence needs a relook. To study prevalence of retinopathy and nephropathy in Type 2 diabetes mel Aim: litus. Comparison of diabetic retinopathy and nephropathy in Type 2 diabetes mellitus and its correlation of diabetic retinopathy and nephropathy with duration of illness and various risk factors that affects development, progression and severity of diabetic retinopathy and nephropathy. 100 diabetic patients were taken up for study for a period of one year meeti Methodology: ng the criteria for the present study. Detailed history was taken from patient and meticulous examination was done of all patients with special emphasis on renal and ophthalmic symptoms. Clinical data and investigation prole was tabulated. Statistical analysis was done. Among 100 patients, 22 had diabetic retinopathy. Among patients with diab Results & Conclusion: etic retinopathy, 68.18% patients had positive family history. Among 100 patients, 32 had diabetic nephropathy, mean FBS was 207 mg%, PPBS was 317.8 mg% and mean HbA was 9.2%. Among patients with diabetic retinopathy, mean FBS was 211 mg%, PPBS was 324.9 1c mg%, HbA was 9.5%. From this study it is found that diabetic nephropathy starts earlier than retinopathy. In this study 1c hypertension was found to accelerate progression into nephropathy and retinopathy.

scholarly journals Prevalence of Non alcoholic fatty liver disease in type 2 diabetes mellitus paients

2016 ◽  
Vol 7 (2) ◽  
pp. 97
Author(s):  
Basaveshwar Jagannath Mhetre ◽  
Rajesh M Honnutagi ◽  
M S Biradar ◽  
Shankargouda S Patil ◽  
Darshan BiradarPatil ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Liver Disease ◽  
Fatty Liver ◽  
Fatty Liver Disease ◽  
Alcoholic Fatty Liver ◽  
Alcoholic Fatty Liver Disease

Systematic investigation of the mechanism of Cichorium glandulosum on type 2 diabetes mellitus accompanied with non-alcoholic fatty liver rats

2019 ◽  
Vol 10 (5) ◽  
pp. 2450-2460 ◽  
Author(s):  
Huiyu Qin ◽  
Haijun Chen ◽  
Yang Zou ◽  
Xiaoyi Zhang ◽  
Changqing Wei ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Fatty Liver ◽  
Systematic Investigation ◽  
Systems Pharmacology ◽  
Active Compounds ◽  
Alcoholic Fatty Liver ◽  
Action Mechanisms

Strategy of this systems-pharmacology approach to investigate the active compounds and action mechanisms of CG on T2DM-NAFLD.

Sign in / Sign up

Export Citation Format

Share Document